Drug intelligence / Profile preview

calcium levulinate

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

Calcium levulinate is a relatively new, highly bioavailable organic salt of calcium derived from the reaction of levulinic acid and calcium hydroxide. It is used as a pharmaceutical preparation for treating acute or chronic hypocalcemia and other conditions requiring rapid elevation of serum calcium levels. The compound features high solubility (over 30% at 25°C), neutral pH, and low irritation potential, making it suitable for oral, parenteral (injection/infusion), and food fortification applications. Calcium levulinate provides approximately 14.8% more elemental calcium than commonly used alternatives like calcium lactate. Its mechanism involves dissociation in the gastrointestinal tract or bloodstream to release free Ca2+ ions, which are then absorbed to replenish body stores[1][2][5][6][7]. Calcium levulinate is also widely used as a food fortifier in beverages, dairy products, soy products, sauces, and other foods due to its high solubility and stability[1][2][3][4]. It is considered non-toxic and non-allergenic with good taste profile[5]. No specific brand names were identified; it is generally marketed under its generic name.

Other names
calcium levulinate dihydrate

Beyond the preview

Go deeper on calcium levulinate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on calcium levulinate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call